Transplantation with Human Placental Stem Cells Improves Diabetes Complications in Rats

News A team of researchers in China has found that transplanting human placenta-derived mesenchymal stem cells (MSCs) into rats modeled with diabetes can affect blood vessel growth. Contributed Author:  Cell Transplantation Center of Excellence for Aging and Brain Repair Topics:  Diabetes